Call Options

10 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$111.15 - $128.97 $3.99 Million - $4.63 Million
-35,900 Reduced 79.6%
9,200 $1.04 Million
Q2 2024

Aug 14, 2024

SELL
$123.8 - $132.96 $854,220 - $917,424
-6,900 Reduced 13.27%
45,100 $5.58 Million
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $2.45 Million - $2.85 Million
21,600 Added 71.05%
52,000 $6.86 Million
Q4 2023

Feb 14, 2024

SELL
$100.18 - $109.02 $13.1 Million - $14.3 Million
-131,100 Reduced 81.18%
30,400 $3.31 Million
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $617,700 - $685,980
6,000 Added 3.86%
161,500 $16.6 Million
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $4.26 Million - $4.64 Million
-39,200 Reduced 20.13%
155,500 $17.9 Million
Q1 2023

May 15, 2023

SELL
$102.94 - $114.86 $5.45 Million - $6.08 Million
-52,900 Reduced 21.37%
194,700 $20.7 Million
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $4.97 Million - $6.37 Million
-56,800 Reduced 18.66%
247,600 $27.5 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $1.94 Million - $2.17 Million
22,900 Added 8.13%
304,400 $26.2 Million
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $23.5 Million - $26.6 Million
281,500 New
281,500 $25.7 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.